Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Lymphoma, B-Cell × tisagenlecleucel × Clear all

Phase

Status

Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1

Interventions

fludarabine 3 Cyclophosphamide 3 relmacabtagene autoleucel 2 Rituximab 2 ALT-803 2 zanubrutinib 1 tisagenlecleucel 1 tafasitamab 1 resiniferatoxin 1 obinutuzumab 1 Tretinoin 1 Radiotherapy 1 Nivolumab 1 Interleukin-2 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04419909 2025-07-02

Retreatment With CTL019/CTL119

University of Pennsylvania

Phase 1 Not yet recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡